Thursday, 30 August 2012

Vitamin B3 (Niacin)


Vitamin B3 (Niacin)

Overview:

Vitamin
B3 is one of 8 B vitamins. It is also known as niacin (nicotinic acid) and has 2 other forms, niacinamide (nicotinamide) and inositol hexanicotinate, which have different effects from niacin.
All B vitamins help the body to convert food (carbohydrates) into fuel (glucose), which is used to produce energy. These B vitamins, often referred to as B complex vitamins, also help the body use fats and protein. B complex vitamins are needed for healthy skin, hair, eyes, and liver. They also help the nervous system function properly.
Niacin also helps the body make various sex and stress-related hormones in the adrenal glands and other parts of the body. Niacin helps improve circulation.
All the B vitamins are water-soluble, meaning that the body does not store them.
You can meet all of your body's needs for B3 through diet. It is rare for anyone in the developed world to have a B3 deficiency. In the United States, alcoholism is the main cause of vitamin B3 deficiency.
Symptoms of mild deficiency include indigestion, fatigue, canker sores, vomiting, and depression. Severe deficiency can cause a condition known as pellagra. Pellagra is characterized by cracked, scaly skin, dementia, and diarrhea. It is generally treated with a nutritionally balanced diet and niacin supplements. Niacin deficiency also causes burning in the mouth and a swollen, bright red tongue.
Very high doses of B3, available by prescription, have been studied to prevent or improve symptoms of the following conditions. However, at high doses niacin can be toxic. You should not take doses higher than the Recommended Daily Allowance except under your doctor's supervision. Researchers are trying to determine if inositol hexanicotinate has similar benefits without serious side effects, but so far results are preliminary.
High Cholesterol
Niacin -- but not niacinamide -- has been used since the 1950s to try to lower elevated LDL ("bad") cholesterol and triglyceride (fat) levels in the blood. However, side effects can be unpleasant and even dangerous. High doses of niacin cause flushing of the skin, stomach upset (which usually subsides within a few weeks), headache, dizziness, and blurred vision. There is an increased risk of liver damage. A time-release form of niacin reduces flushing, but its long-term use is associated with liver damage. In addition, niacin can interact with other cholesterol-lowering drugs (see "Possible Interactions"). You should not take niacin at high doses without your doctor's supervision.
Atherosclerosis and Heart Disease
In one study, men with existing heart disease slowed down the progression of atherosclerosis by taking niacin along with colestipol. They had fewer heart attacks and deaths, as well.
In another study, people with heart disease and high cholesterol who took niacin along with simvastatin (Zocor) had a lower risk of having a first heart attack or stroke. Their risk of death was also lower. In another study, men who took niacin alone seemed to reduce the risk of having a second heart attack, although it did not reduce the risk of death.
Diabetes
Some evidence suggests that niacinamide (but not niacin) might help delay the time that you would need to take insulin in type 1 diabetes. In type 1 diabetes, the body's immune system mistakenly attacks the cells in the pancreas that make insulin, eventually destroying them. Niacinamide may help protect those cells for a time, but more research is needed to tell for sure.
Researchers have also looked at whether high-dose niacinamide might reduce the risk of type 1 diabetes in children at risk for the disease. One study found that it did, but another, larger study found it did not protect against developing type 1 diabetes. More research is needed to know for sure.
The effect of niacin on type 2 diabetes is more complicated. People with type 2 diabetes often have high levels of fats and cholesterol in the blood. Niacin, often along with other drugs, can lower those levels. However, niacin may also raise blood sugar levels, which is particularly dangerous for someone with diabetes. For that reason, anyone with diabetes should take niacin only when directed to do so by their doctor, and should be carefully monitored for high blood sugar.
Osteoarthritis
One preliminary study suggested that niacinamide may improve arthritis symptoms, including increasing joint mobility and reducing the amount of nonsteroidal anti-inflammatory drugs (NSAIDs) needed. More research is needed.
Other
Alzheimer's disease -- Population studies show that people who get higher levels of niacin in their diet have a lower risk of Alzheimer's disease. No studies have evaluated niacin supplements, however.
Cataracts -- One large population study found that people who got a lot of niacin in their diets had a lower risk of developing cataracts.
Skin conditions -- Researchers are studying topical forms of niacin as treatments for rosacea, aging, and prevention of skin cancer, although it's too early to know whether it is effective.
Researchers are also studying the use of vitamin B3 in treating ADHD, migraines, dizziness, depression, motion sickness, and alcohol dependence. But there is no evidence that it helps treat any of these conditions.

Dietary Sources:

The best food sources of vitamin B3 are found in beets, brewer's yeast, beef liver, beef kidney, fish, salmon, swordfish, tuna, sunflower seeds, and peanuts. Bread and cereals are usually fortified with niacin. In addition, foods that contain tryptophan, an amino acid the body coverts into niacin, include poultry, red meat, eggs, and dairy products.

Available Forms:

Vitamin B3 is available in several different supplement forms: niacinamide, niacin, and inositol hexaniacinate. Niacin is available as a tablet or capsule in both regular and timed-release forms. The timed-release tablets and capsules may have fewer side effects than regular niacin. However, the timed-release versions are more likely to cause liver damage. Regardless of which form of niacin you're using, doctors recommend periodic liver function tests when using high doses (above 100 mg per day) of niacin.

How to Take It:

Daily recommendations for niacin in the diet of healthy individuals are listed below.
Generally, high doses of niacin are used to control specific diseases. Such high doses must be prescribed by a doctor, who will have you increase the amount of niacin slowly, over the course of 4 - 6 weeks, and take the medicine with meals to avoid stomach irritation.
Pediatric
  • Infants birth - 6 months: 2 mg (adequate intake)
  • Infants 7 months - 1 year: 4 mg (adequate intake)
  • Children 1- 3 years: 6 mg (RDA)
  • Children 4 - 8 years: 8 mg (RDA)
  • Children 9 - 13 years: 12 mg (RDA)
  • Boys 14 - 18 years: 16 mg (RDA)
  • Girls 14 - 18 years: 14 mg (RDA)
Adult
  • Men 19 years and older: 16 mg (RDA)
  • Women 19 years and older: 14 mg (RDA)
  • Pregnant women: 18 mg (RDA)
  • Breastfeeding women: 17 mg (RDA)

Precautions:

Because of the potential for side effects and interactions with medications, you should take dietary supplements only under the supervision of a knowledgeable health care provider.
High doses (50 mg or more) of niacin can cause side effects. The most common side effect is called "niacin flush," which is a burning, tingling sensation in the face and chest, and red or flushed skin. Taking an aspirin 30 minutes prior to the niacin may help reduce this symptom.
At the very high doses used to lower cholesterol and treat other conditions, liver damage and stomach ulcers can occur. Your health care provider will regularly check your liver function through a blood test.
People with a history of liver disease, kidney disease, or stomach ulcers should not take niacin supplements. Those with diabetes or gallbladder disease should do so only under the close supervision of their doctor.
Stop taking niacin or niacinamide at least two weeks before a scheduled surgery.
Niacin and niacinamide may make allergies worse by increasing histamine.
People with low blood pressure should not take niacin or niacinamide because they may cause a dangerous drop in blood pressure. Don' t take niacin if you have a history of gout.
People with coronary artery disease or unstable angina should not take niacin without their doctor' s supervision, as large doses can raise the risk of heart rhythm problems.
Taking any one of the B vitamins for a long period of time can result in an imbalance of other important B vitamins. For this reason, you may want to take a B complex vitamin, which includes all the B vitamins.

Possible Interactions:

If you are currently taking any of the following medications, you should not use niacin without first talking to your health care provider.
Antibiotics, Tetracycline -- Niacin should not be taken at the same time as the antibiotic tetracycline because it interferes with the absorption and effectiveness of this medication. All vitamin B complex supplements act in this way and should be taken at different times from tetracycline.
Aspirin -- Taking aspirin before taking niacin may reduce flushing from niacin, but take it only under your doctor's supervision.
Anti-seizure Medications -- Phenytoin (Dilantin) and valproic acid (Depakote) may cause niacin deficiency in some people. Taking niacin with carbamazepine (Tegretol) or mysoline (Primidone) may increase levels of these medications in the body.
Anticoagulants (blood thinners) -- Niacin may make the effects of these medications stronger, increasing the risk of bleeding.
Blood Pressure Medications, Alpha-blockers -- Niacin can make the effects of medications taken to lower blood pressure stronger, leading to the risk of low blood pressure.
Cholesterol-lowering Medications -- Niacin binds the cholesterol lowering medications known as bile-acid sequestrants and may make them less effective. For this reason, niacin and these medications should be taken at different times of the day. Bile-acid sequestrants include colestipol (Colestid), colesevelam (Welchol), and cholestyramine (Questran).
Statins -- Some scientific evidence suggests that taking niacin with simvastatin (Zocor) appears to slow down the progression of heart disease. However, the combination may also increase the likelihood for serious side effects, such as muscle inflammation or liver damage.
Diabetes Medications -- Niacin may increase blood sugar levels. People taking insulin, metformin (Glucophage), glyburide (Dibeta, Micronase), glipizide (Glucotrol), or other medications used to treat high blood glucose levels should monitor their blood sugar levels closely when taking niacin supplements.
Isoniazid (INH) -- INH, a medication used to treat tuberculosis, may cause a niacin deficiency.
Nicotine Patches -- Using nicotine patches with niacin may worsen or increase the risk of flushing associated with niacin.
These medications may lower levels of niacin in the body:
  • Azathioprine (Imuran)
  • Chloramphenicol (Chloromycetin)
  • Cycloserine (Seromycin)
  • Fluorouracil
  • Levodopa and carbidopa
  • Mercaptopurine (Purinethol)

Alternative Names:

Inositol hexaniacinate; Niacin; Niacinamide; Nicotinamide; Nicotinic acid
  • Reviewed last on: 8/31/2011
  • A.D.A.M. Editorial Team: David Zieve, MD, MHA, and David R. Eltz. Previously reviewed by Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network (6/12/2011).

Supporting Research

AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2.
Bissett DL, Oblong JE, Berge CA, et al. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31:860-865; discussion 865.
Brown BG, Zhao XQ, Chalt A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345(22):1583-1592.
Cumming RG, Mitchell P, Smith W. Diet and cataract: the Blue Mountains Eye Study. Ophthalmology. 2000;107(3):450-456.
Draelos ZD, Ertel K, Berge C, et al. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-141.
Elam M, Hunninghake DB, Davis KB, et al. Effects of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000;284:1263-1270.
Garcia-Closas R. et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer. 2007;43(11):1731-40.
Goldberg A, Alagona P, Capuzzi DM, et al. Multiple-dose efficacy and safety of an extended-release form of niacin in management of hyperlipidemia. Am J Cardiol. 2000;85:1100-1105.
Guyton JR. Niacin in cardiovascular prevention: mechanisms, efficacy, and safety. Curr Opin Lipidol. 2007 Aug;18(4):415-20.
Jacques PF, Chylack LT Jr, Hankinson SE, et al. Long-term nutrient intake and early age related nuclear lens opacities. Arch Ophthalmol. 2001;119(7):1009-1019.
Kuzniarz M, Mitchell P, Cumming RG, Flood VM. Use of vitamin supplements and cataract: the Blue Mountains Eye Study. Am J Ophthalmol. 2001;132(1):19-26.
Mittal MK, Florin T, Perrone J, Delgado JH, Osterhoudt KC. Toxicity from the use of niacin to beat urine drug screening. Ann Emerg Med. 2007;50(5):587-90.
Nutrients and Nutritional Agents. In: Kastrup EK, Hines Burnham T, Short RM, et al, eds. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 2000:4-5.
Raja R, Thomas JM, Greenhill-Hopper M, Ley SV, Almeida Paz FA. Facile, one-step production of niacin (vitamin B3) and other nitrogen-containing pharmaceutical chemicals with a single-site heterogeneous catalyst. Chemistry. 2008;14(8):2340-8.
Sanyal S, Karas RH, Kuvin JT. Present-day uses of niacin: effects on lipid and non-lipid parameters. Expert Opin Pharmacother. 2007 Aug;8(11):1711-7.
Torkos S. Drug-nutrient interactions: a focus on cholesterol-lowering agents. Int J Integrative Med. 2000;2(3):9-13.
Wolerton: Comprehensive Dermatalogic Drug Therapy, 2nd ed. Philadelphia, PA: Saunders Elsevier. 2007.
Zhao H, Yang X, Zhou R, Yang Y. Study on vitamin B1, vitamin B2 retention factors in vegetables. Wei Sheng Yan Jiu. 2008;37(1):92-6.


Read more: http://www.umm.edu/altmed/articles/vitamin-b3-000335.htm#ixzz2520UrkZZ

tuberculosis in Africa, Asia, Europe and Latin America


* Eight country study finds high rates of drug resistance
* Resistant strains more costly to treat, often more fatal
* Almost 9 million people a year get TB, 1.4 million die (Adds expert comment on drug costs, vaccines)
By Kate Kelland
LONDON, Aug 30 (Reuters) - Scientists have found an alarming number of cases of the lung disease tuberculosis in Africa, Asia, Europe and Latin America that are resistant to up to four powerful antibiotic drugs.
In a large international study published in the Lancet medical journal on Thursday, researchers found rates of both multi drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) were higher than previously thought and were threatening global efforts to curb the spread of the disease.
"Most international recommendations for TB control have been developed for MDR-TB prevalence of up to around 5 percent. Yet now we face prevalence up to 10 times higher in some places, where almost half of the patients ... are transmitting MDR strains," Sven Hoffner of the Swedish Institute for Communicable Disease Control, said in a commentary on the study.
TB is already a worldwide pandemic that infected 8.8 million people and killed 1.4 million in 2010.
Drug-resistant TB is more difficult and costly than normal TB to treat, and is more often fatal.
MDR-TB is resistant to at least two first-line drugs - isoniazid and rifampicin - while XDR-TB is resistant to those two drugs as well as a powerful antibiotic type called a fluoroquinolone and a second-line injectable antibiotic.
Treating even normal TB is a long process, with patients needing to take a cocktail of powerful antibiotics for six months. Many patients fail to complete their treatment correctly, a factor which has fuelled a rise in the drug-resistant forms.
Researchers who studied rates of the disease in Estonia, Latvia, Peru, the Philippines, Russia, South Africa, South Korea and Thailand found almost 44 percent of cases of MDR TB were also resistant to at least one second-line drug.
Tom Evans, chief scientific officer at Aeras, a non-profit group working to develop new TB vaccines, told Reuters treatment options for XDR-TB patients were "limited, expensive and toxic".
Treatments for drug-resistant TB can cost 200 times more than those for normal TB, he said in an emailed statement. They can also cause severe side effects like deafness and psychosis, and can take two years to complete, he added.
In the United States, MDR-TB treatment can cost $250,000 or more per patient, and in many poorer countries costs can be catastrophic to health systems and patients' families.
"Without a robust pipeline of new drugs to stay one step ahead, it will be nearly impossible to treat our way out of this epidemic," Evans said.
SPREADS THROUGH AIR
Tracy Dalton from the United States Centers for Disease Control and Prevention, who led the Lancet study, said that so far, XDR-TB has been reported in 77 countries worldwide.
"As more individuals are diagnosed with, and treated for, drug-resistant TB, more resistance to second-line drugs is expected to emerge," she said.
The spread of these drug-resistant strains was "particularly worrisome" in areas with poor healthcare resources and limited access to effective drugs, she added.
TB is a bacterial infection that destroys patients' lung tissue, making them cough and sneeze and spread germs through the air. Experts say anyone with active TB can easily infect another 10 to 15 people a year.
The World Health Organisation (WHO) predicts more than 2 million people will contract MDR TB by 2015.
A report by non-governmental organisations in March said a $1.7 billion shortfall in funds to fight TB over the next five years meant 3.4 million patients would go untreated and gains made against the disease will be reversed.
In their research, Dalton and colleagues found rates of resistance varied widely between countries.
Overall, resistance to any second-line drug was detected in nearly 44 percent of patients, ranging from 33 percent in Thailand to 62 percent in Latvia.
In about a fifth of cases, they found resistance to at least one second-line injectable drug. This ranged from 2 percent in the Philippines to 47 percent in Latvia.
XDR-TB was found in 6.7 percent of patients overall. Rates in South Korea, at 15.2 percent, and Russia at 11.3 percent, were more than twice the WHO's global estimate of 5.4 percent at that time. (Editing by Andrew Heavens)

Wednesday, 29 August 2012

Personal care costs rise by 150% in seven years


Personal care costs rise by 150% in seven years

Generic image of pensionersAbout 77,000 people now receive help in their own homes and in care homes

Related Stories

The cost of providing free personal care to people in their own homes has risen by more than 150% in seven years, according to the Scottish government.
Helping people with personal care such as washing and dressing cost £342m in 2010-11, up from £133m in 2003-04.
The government said the rise reflected the fact that an increasing proportion of older people were cared for at home rather than in hospital or care homes.
Personal care costs for people in care homes rose by 25%, from £86m to £108m.
Personal or nursing care payments are available to self-funding care home residents who have assets, including property, worth more than £23,500.
The number of people receiving these payments to help pay their care home fees increased steadily in the first few years of the policy. Currently, just under a third of all older people in care homes receive the payments.
The number of people receiving free personal care at home has also increased by 42% over the same period, from 32,870 in 2003-04 to 46,720 in 2010-11.

Start Quote

A responsible government in Scotland cannot ignore the facts, kidding everyone on that everything and anything is affordable”
Jackson CarlawScottish Tory health spokesman
Free personal care was introduced by the Scottish government in 2002, and the policy was reviewed in 2008.
About 77,000 people in Scotland now receive help in their own homes and in care homes compared with 64,000 when the policy was first introduced.
Jackson Carlaw, Scottish Conservative health spokesman and deputy leader MSP, said: "If the SNP wants to continue funding free personal care, then it has to be far less casual in extending other entitlements and refusing to find ways to make them more sustainable.
"That is why we opposed free prescriptions, and why we want to align free transport to the pensionable age in future.
"A responsible government in Scotland cannot ignore the facts, kidding everyone on that everything and anything is affordable. We all know that there is an unprecedented demographic challenge waiting around the corner."
Jackie Baillie, Scottish Labour's health speaker, said her party was fully committed to the policy.
But she added: "My fear is the quality of care we provide for people will be compromised as a result of the strain on finances and the elderly and the vulnerable will pay another kind of price in a drop in standards of care.
"We have previously suggested creating a National Care Service to join up budgets and set a minimum standard of care but are open to working with the Scottish government to look at ways to ensure personal care is sustainable in the long-term."
'Greatly valued service'
Health Secretary, Nicola Sturgeon, said: "These figures show that each year an increasing number of older people continue to benefit from free personal and nursing care.
"This reflects the Scottish government's focus on more intensive support to frail older people at home or in a homely setting, as well as the continuing shift in the balance of care towards providing care at home.
"We are fully committed to the funding of free personal care for the elderly, a service greatly valued by the people of Scotland.
"The challenges posed by an ageing population demonstrate why we want to see health and social care for adults delivered in an integrated way by NHS.

More on This Story

Related Stories

Sunday, 26 August 2012

twice the number of measles cases


Measles cases 'almost double' after outbreaks


Measles is on the rise
There have been almost twice the number of measles cases in England and Wales in the first six months of this year compared with the same period last year, official figures show.
The figure had risen from 497 to 964, the Health Protection Agency said.
MeaslesThere are currently significant measles outbreaks in Merseyside and Sussex.
The agency is urging parents to ensure children are up to date with their measles, mumps and rubella (MMR) vaccinations before the school begins.
Measles can cause serious illness and can, in some cases, be fatal.
Complications can include meningitis and encephalitis - inflammation of the lining of the brain. Rarer disorders of the eye, heart and nervous system can also develop.
Rubella, known as German measles, has also increased, with 57 cases reported between January and June in England and Wales - more than the annual totals for each of the previous nine years.
Most cases are linked to travel to other European countries.

Latest data on immunisations across England shows uptake rates of 93% for the first MMR jab and 87% for the second.
It is usually a mild infection. But if a woman becomes infected in early pregnancy, it can cause birth defects.
In Wales, the figures are 92% and 87%.
The first dose of the MMR vaccine should ideally be given to children between 12 to 13 months of age.
They are given the second dose before they start school, usually between three and five years of age, although it can be given three months after the first.
'Best protection'
Dr Mary Ramsay, head of immunisation at the Health Protection Agency, said: "Measles can be very serious and parents should understand the risks associated with the infection, which in severe cases can result in death.
"Although uptake of the MMR has improved in recent years some children do not get vaccinated on time and some older children, who missed out when uptake was lower, have not had a chance to catch up.
"Therefore, there are still enough people who are not protected to allow some large outbreaks to occur among unvaccinated individuals."
She added: "It's vital that children receive both doses of the MMR vaccination and ahead of returning to school after the holidays, we are urging parents to ensure their children have received the two doses, which will provide the best protection against the risks associated with measles, mumps and rubella."
The HPA is advising parents to check with their GP to see if their child has had both doses of MMR.

struck off


Ian Tomlinson pathologist Dr Freddy Patel struck off


A medical tribunal earlier concluded he acted with "deficient professional performance" over his examination.
The pathologist who conducted the first post-mortem tests on a man who died in 2009's G20 protests in London has been struck off the medical register.
Dr Freddy Patel wrongly said Ian Tomlinson died from heart problems.
PC Simon Harwood, who had pushed Mr Tomlinson to the ground but was cleared of manslaughter, is facing Met Police disciplinary proceedings in September.
Mr Tomlinson's widow, Julia, said she was "pleased" Dr Patel had been struck off and would not be able to put other families through their ordeal.
Dr Patel's conclusion that the newspaper seller died of a cardiac arrest was questioned when a video emerged showing him being pushed and struck with a baton by PC Harwood.
Dr Freddy PatelFurther medical reports suggested he had actually died from an injury to his liver that caused internal bleeding and then cardiac arrest.
Earlier this week, the Medical Practitioners Tribunal Service said Dr Patel's work was "deficient" and ruled that he is not fit to practise.
In total, 68 failings were identified by the service in Dr Patel's work on the case of Mr Tomlinson.

Start Quote

We asked for him to be removed from the register as the best way of protecting the public”
Niall DicksonGeneral Medical Council
Reacting to the ruling earlier in the week, Julia, said Dr Patel's "incompetence" had given the family "an uphill battle for justice from the start".
An inquest jury found that Mr Tomlinson had been unlawfully killed but PC Harwood was cleared of killing him at a subsequent crown court trial.
Dr Patel, who qualified at the University of Zambia in 1974 and has practised as a pathologist for 35 years, did not attend the Medical Practitioners Tribunal Service (MPTS), sitting in Manchester on Thursday.
He was excused attendance to look after his sick wife but listened in on the hearing by conference call from London.
The Rev Robert Lloyd-Richards, who chairs the MPTS fitness to practise panel, said Dr Patel had an "unwarranted confidence" in his ability, "a deep-seated attitudinal problem" and also "lacked insight".
The General Medical Council said it welcomed the decision.
Ian Tomlinson on the groundAfter his death footage emerged of Mr Tomlinson being pushed to the ground
Niall Dickson, its chief executive, said: "This means he is no longer able to practise as a doctor in the UK.
"We asked for him to be removed from the register as the best way of protecting the public because his conduct fell far below the standards we expect of a doctor."
Last year, Dr Patel was given a four-month ban for dishonesty and omitting key findings after examining the body of a murder victim who he said had died from natural causes.
Sally White, who was murdered by Anthony Hardy in north London in 2002, had injuries which included a bite mark and a head wound. Hardy went on to murder two more women later that year.
Dr Patel also served a three-month suspension for failings in other cases and had been removed from the official register of approved forensic pathologists.
Meanwhile, Scotland Yard has said that PC Harwood's gross misconduct hearing - which is expected to last up to four weeks - will be held in front of a panel of three people, including a senior officer and a lay person.
It comes after the Independent Police Complaints Commission ordered that PC Harwood should face the internal hearing in public

Thursday, 23 August 2012

Audit Commission urges social care savings


Audit Commission urges social care savings o£300mPeople inside a day centre for the elderly

The commission said there were wide variations in the costs of assessing clients
Councils in England could save £312m annually on adult social care if they carried out client assessments more effectively, the Audit Commission says.
The public spending watchdog said some councils conducted reviews at the same quality as others but more cheaply.
The commission said any chance for councils to save money in this area should be "pursued enthusiastically".
Councils said efficiency savings could not offset a shortfall of billions of pounds in care budgets.
'Crucial element'
Every council in England is responsible for helping with the care of the elderly, the seriously ill and the disabled.
But the cost of assessing these people, to find out what level of assistance is needed, varies widely.
In 2010/11, English councils did about 1.8m assessments of people's needs and reviews of the resulting care, at a cost of £2.2bn - 12% of gross spending on adult social care, the commission said.
Audit Commission managing director Andy McKeon said: "Assessments and reviews are a crucial element of social care, enabling individuals' needs to be properly identified and met.
"However, our evidence suggests that councils can spend less and still do an excellent job in helping people receive the care that they need.
"As councils struggle to meet the needs of a growing older population with less cash, any opportunity to save money and redirect it into care should be pursued enthusiastically."
Quality standards
In its report, the commission found that some councils spent about half the amount of other councils on each assessment and review.
This was done, the commission said, while undertaking a similar volume of work and achieving the same standards of quality.
It said the potential savings could fund the annual home care of 20,000 older people.
Many councils would be able to make significant savings by identifying and eliminating the causes of differences in costs, it added.
The Local Government Association said councils were always working hard to offer the best value for money.
But it said local authorities faced a massive cash shortfall because of reduced government funding and an increasing elderly population.
The BBC is not responsible for the content of external Internet sites

Wednesday, 22 August 2012

NHS hospital trusts invited to expand abroad


NHS hospital trusts invited to expand abroad

NHS staff from Great Ormond Street Hospital took part in the London 2012 Olympic Opening Ceremony

An agency will aim to link hospitals such as Great Ormond Street with foreign governments that want access to British-run health services.
High-profile NHS hospitals in England are to be encouraged by the government to set up profit-making branches abroad to help fund services in the UK.
Investment would have to be drawn from hospitals' private UK work, but with profits ploughed back into the NHS.
A patients' group said the move was a "distraction" at a time of "upheaval".
The drive, building on an initiative first started under the Labour government, is set to be launched by the Department of Health and UK Trade and Investment this autumn.
The BBC understands the initiative is unlikely to involve regular district or general hospitals but would target world-renowned hospitals like the Royal Marsden, Great Ormond Street and Guy's and St Thomas'.

David Stou

'Benefit patients'
NHS staff taking part in the London 2012 Olympic opening ceremony It would mirror schemes such as that of Moorfields Eye Hospital in London, which in 2007 built a unit of the same name in Dubai. Children's hospital Great Ormond Street also has interests abroad.
In 2010, Labour's Health Secretary Andy Burnham set up NHS Global to help the health service make the most of the global market for healthcare and the coalition now wants to build on this.
A source close to current Health Secretary Andrew Lansley emphasised that hospitals would be able to pay for their investments abroad using only revenue generated from their private patients in the UK.
Any profits made overseas would be ploughed back into the health service and so benefit NHS patients, the source added.
The Health and Social Care Act, which was passed by Parliament earlier this year, eased the way for hospital trusts to expand their work in the private sector.
Health Minister Anne Milton said: "This is good news for NHS patients who will get better services at their local hospital as a result of the work the NHS is doing abroad and the extra investment that will generate.
"This is also good news for the economy, which will benefit from the extra jobs and revenue created by our highly successful life sciences industries as they trade more across the globe.
"The NHS has a world-class reputation, and this exciting development will make the most of that to deliver real benefits for both patients and taxpayers."
Moorfields medical director Chris Canning said no taxpayers' money had been spent on its Dubai venture and it had been in profit for the past three years while "raising the reputation and profile" of the NHS and the hospital, and making money to reinvest in UK health services.
David Stout, deputy chief executive of the NHS Confederation, which represents organisations around England, denied the scheme would divert attention away from health services and said an international exchange of ideas could in fact improve local services.
"This is not about distorting what the NHS offers to UK citizens, this is about how we can exploit the brand of the NHS internationally," he told BBC Radio 4's Today Programme.
When asked if the NHS could end up under-funded by taxation because of increasing funds raised abroad, he said: "We are not talking about completely skewing the way the health service funding comes in - this will be marginal in the scheme of a £100bn organisation organisation in the NHS."
'Rampant commercialisation'
However, the move was criticised by the Patients Association.
"The key and only focus of an NHS hospital should be to provide treatment to patients on the NHS. We would be very concerned by any moves which would see commercial ventures, which are naturally going to be important for hospitals because they need to use them to raise revenue, would simply result in the attention of the hospitals being taken away from the core purpose - to treat patients in the UK and instead be focused on these hospitals abroad," said Michael Watson, of the group.
Andy Burnham, Labour: "The government's plan fundamentally alters the character of the NHS"
Labour began the initiative while in government, but shadow health minister Jamie Reed criticised the coalition's plans.
He said: "At a time when staff are losing their jobs and waiting times are rising, the government's priority should be sorting out the mess it has created in our NHS.
"Under David Cameron we're seeing a rampant commercialisation of the NHS. He needs to get a grip and start focusing on patients, not profits."

Featured post

More patients in Scotland given antidepressants

More patients in Scotland given antidepressants 13 October 2015   From the section Scotland Image copyright Thinkstock Image ca...